Personalized medicine: new genomics, old lessons

par Offit, Kenneth
Publié 2011

The Future of Clinical Cancer Genomics

par Offit, Kenneth
Publié dans Semin Oncol (2016)

Heterozygous Mutations in DNA Repair Genes and Hereditary Breast Cancer: A Question of Power

par Ellis, Nathan A., Offit, Kenneth
Publié 2012

Ethical and Legal Implications of Cancer Genetic Testing: Do Physicians Have a Duty to Warn Patients' Relatives About Possible Genetic Risks?

par Storm, Courtney, Agarwal, Rinki, Offit, Kenneth
Publié 2008

Association of a HOXB13 Variant with Breast Cancer

par Alanee, Shaheen, Couch, Fergus, Offit, Kenneth
Publié 2012

Revealing the Incidentalome When Targeting the Tumor Genome

par Bombard, Yvonne, Robson, Mark, Offit, Kenneth
Publié 2013

Genitourinary Cancers Other than Prostate Cancer in a BRCA-tested Cohort from a Single Institution

par Alanee, Shaheen, Schrader, Kasmintan, Offit, Kenneth
Publié dans Eur Urol (2015)

Two Decades After BRCA: Setting Paradigms in Personalized Cancer Care and Prevention

par Couch, Fergus J., Nathanson, Katherine L., Offit, Kenneth
Publié 2014

A Rapid and Reliable Test for BRCA1 and BRCA2 Founder Mutation Analysis in Paraffin Tissue Using Pyrosequencing

par Zhang, Liying, Kirchhoff, Tomas, Yee, Cindy J., Offit, Kenneth
Publié 2009

Genomic Biomarkers for Breast Cancer Risk

par Walsh, Michael F., Nathanson, Katherine L., Couch, Fergus J., Offit, Kenneth
Publié dans Adv Exp Med Biol (2016)

Cancer Genomics and Inherited Risk

par Stadler, Zsofia K., Schrader, Kasmintan A., Vijai, Joseph, Robson, Mark E., Offit, Kenneth
Publié dans J Clin Oncol (2014)

Tissue-Specific Enrichment of Lymphoma Risk Loci in Regulatory Elements

par Hayes, James E., Trynka, Gosia, Vijai, Joseph, Offit, Kenneth, Raychaudhuri, Soumya, Klein, Robert J.
Publié dans PLoS One (2015)

Absence of loss of heterozygosity of BRCA1 in a renal tumor from a BRCA1 germline mutation carrier

par Alanee, Shaheen, Shah, Sohela, Murali, Rajmohan, Rau-Murthy, Rohini, Schrader, Kasmintan A., Offit, Kenneth
Publié dans Fam Cancer (2013)

Gene Patents and Personalized Cancer Care: Impact of the Myriad Case on Clinical Oncology

par Offit, Kenneth, Bradbury, Angela, Storm, Courtney, Merz, Jon F., Noonan, Kevin E., Spence, Rebecca
Publié dans J Clin Oncol (2013)

A case for expert curation: an overview of cancer curation in the Clinical Genome Resource (ClinGen)

par Ritter, Deborah I., Rao, Shruti, Kulkarni, Shashikant, Madhavan, Subha, Offit, Kenneth, Plon, Sharon E.
Publié dans Cold Spring Harb Mol Case Stud (2019)

Genetics, Genomics and Cancer Risk Assessment: State of the art and future directions in the era of personalized medicine

par Weitzel, Jeffrey N., Blazer, Kathleen R., MacDonald, Deborah J., Culver, Julie O., Offit, Kenneth
Publié 2011

Variants at IRX4 as prostate cancer expression quantitative trait loci

par Xu, Xing, Hussain, Wasay M, Vijai, Joseph, Offit, Kenneth, Rubin, Mark A, Demichelis, Francesca, Klein, Robert J
Publié 2014

Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk

par Kaklamani, Virginia, Yi, Nengjun, Zhang, Kui, Sadim, Maureen, Offit, Kenneth, Oddoux, Carole, Ostrer, Harry, Mantzoros, Christos, Pasche, Boris
Publié 2011

Variants of the Adiponectin and Adiponectin Receptor 1 Genes and Breast Cancer Risk

par Kaklamani, Virginia G., Sadim, Maureen, Hsi, Alex, Offit, Kenneth, Oddoux, Carole, Ostrer, Harry, Ahsan, Habibul, Pasche, Boris, Mantzoros, Christos
Publié 2008

Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer

par Alanee, Shaheen, Shah, Sohela, Vijai, Joseph, Schrader, Kasmintan, Rau-Murthy, Rohini, Sarrel, Kara, Manschreck, Christopher, Eastham, James, Offit, Kenneth
Publié dans Fam Cancer (2013)